As of Tuesday, Agios Pharmaceuticals, Inc.’s AGIO share price has surged by 16.38%, which has investors questioning if this ...

Agios Pharmaceuticals (AGIO) witnessed a jump in share price last session on above-average trading volume. The latest trend ...

Shares of Agios Pharmaceuticals AGIO have plunged 23% over the past six months, primarily due to pipeline and regulatory setbacks, which have dampened investor confidence in the company’s near-term ...

The young drugmaker's sickle cell treatment is receiving special consideration from the United States' top drug regulator.

Shares of Agios Pharmaceuticals AGIO fell 11% on Thursday after the company announced that the FDA had extended the review timeline for the supplemental new drug application (sNDA) seeking label ...

Focused on therapies for rare blood disorders, this biotech saw a notable insider sale amid ongoing clinical development ...

For those looking to find strong Medical stocks, it is prudent to search for companies in the group that are outperforming their peers. Has Agios Pharmaceuticals (AGIO) been one of those stocks this ...

Agios Pharmaceuticals Inc AGIO shares are trading sharply higher Tuesday afternoon after the company said it will pursue U.S.

Agios Pharmaceuticals stock jumped Tuesday after the company said it would seek an accelerated approval for its sickle cell treatment.

We recently compiled a list of the 10 Cheap Biotech Stocks to Invest in Now. In this article, we are going to take a look at where Agios Pharmaceuticals, Inc. (NASDAQ:AGIO) stands against the other ...